Replaces Prod. #: BML-P403
Potent and reversible inhibitor of caspase-1. Also inhibits caspase-4. Strongly inhibits anti-Fas induced apoptosis in L929-Fas cells.
Product Details
| Alternative Name: | Caspase-1 inhibitor (aldehyde) |
| |
| Sequence: | Ac-Tyr-Val-Ala-Asp-CHO |
| |
| Formula: | C23H32N4O8 |
| |
| MW: | 492.5 |
| |
| Formulation: | Lyophilized. |
| |
| Peptide Content: | 70-90% |
| |
| Purity: | ≥96% (HPLC) |
| |
| Appearance: | White powder. |
| |
| Solubility: | Soluble in DMSO or water (both 50mg/ml). |
| |
| Reconstitution: | Add 0.2ml DMSO per 1.0mg peptide. Shake well until all the contents are dissolved. This furnishes a 10mM solution of this material. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Stock solutions should be divided into aliquots and stored at -20°C. |
| |
| Handling: | Keep under inert gas. Keep cool and dry. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils: I. Demirel, et al.; Sci. Rep.
10, 21837 (2020),
Abstract;
Full Text
Gasdermin D plays a vital role in the generation of neutrophil extracellular traps: G. Sollberger, et al.; Sci. Immunol.
3, eaar6689 (2018),
Abstract;
Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells: N. Pizato, et al.; Sci. Rep.
8, 1952 (2018),
Abstract;
Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells: C. Dai & S.B. Krantz; Blood
93, 3309 (1999),
Abstract;
Inhibition of human caspases by peptide-based and macromolecular inhibitors: M. Garcia-Calvo, et al.; J. Biol. Chem.
273, 32608 (1998),
Abstract;
Full Text
Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways: Y.Z. Lin, et al.; J. Biol. Chem.
271, 3505 (1996),
Abstract;
Full Text
Sequential activation of ICE-like and CPP32-like proteases during Fas- mediated apoptosis: M. Enari, et al.; Nature
380, 723 (1996),
Abstract;
Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro: C.E. Milligan, et al.; Neuron
15, 385 (1995),
Abstract;
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis: M. Los, et al.; Nature
375, 81 (1995),
Abstract;
Crystal structure of the cysteine protease interleukin-1 beta- converting enzyme: a (p20/p10)2 homodimer: N.P.C. Walker, et al.; Cell
78, 343 (1994),
Abstract;
Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones: N.A. Thornberry, et al.; Biochemistry
33, 3934 (1994),
Abstract;
Interleukin-1 beta converting enzyme: N.A. Thornberry; Methods Enzymol.
244, 615 (1994),
Abstract;
Structure and mechanism of interleukin-1 β converting enzyme: K.P. Wilson, et al.; Nature
370, 270 (1994),
Abstract;
Interleukin 1 β (IL-1 β) processing in murine macrophages requires a structurally conserved homologue of human IL-1 β converting enzyme: S.M. Molineaux, et al.; PNAS
90, 1809 (1993),
Abstract;
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes: N.A. Thornberry, et al.; Nature
356, 768 (1992),
Abstract;
Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzyme: K.T. Chapman; Bioorg. Med. Chem. Lett. 2, 613 (1992),
